Non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy - Scientific guideline

Scientific guidelineHumanScientific guidelines

Maltese is available via eTranslation, the European Commission's machine translation service.

Translate to Maltese | Important information about machine translation

This document provides guidance on the evaluation of medicinal products for the prevention of nausea and vomiting associated with cancer chemotherapy.

Keywords: Chemotherapy, nausea, vomiting

Current effective version

Guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy

Adopted Reference Number: CPMP/EWP/4937/03 Legal effective date:

English (EN) (112.3 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Document history

Guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy

Adopted Reference Number: CPMP/EWP/4937/03 Legal effective date:

English (EN) (112.3 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Overview of comments on draft guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy

Reference Number: EMEA/CHMP/EWP/487732/2006

English (EN) (127.49 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Draft guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy

Draft: consultation closed Reference Number: CPMP/EWP/4937/03

English (EN) (83.38 KB - PDF)

Ippubblikat għall-ewwel darba: Aġġornata l-aħħar:
Ara

Share this page